PDK3 Inhibitors

PDK3 inhibitors encompass a diverse array of chemicals designed to modulate cellular metabolism by directly or indirectly interfering with pyruvate dehydrogenase kinase 3 (PDK3). Dichloroacetate (DCA), AZD7545, Nov3r, and Dichloroacetophenone directly target PDK3, inhibiting its activity and promoting pyruvate dehydrogenase complex function. This shift in metabolism favors oxidative phosphorylation over glycolysis, altering the cellular energy landscape. Radicicol and CPI-613 exemplify indirect PDK3 inhibitors. Radicicol modulates HSP90 activity, impacting the stability and function of PDK3, leading to altered pyruvate dehydrogenase complex regulation. CPI-613, an altered mitochondrial metabolism disruptor, indirectly influences PDK3 by affecting mitochondrial function, resulting in downstream effects on glycolysis regulation. Additionally, chemicals like Lipoic Acid, Aminooxyacetic Acid, Imatinib, Sodium Oxamate, Dichloroacetonitrile, and Meldonium contribute to PDK3 inhibition. They either interfere with pyruvate dehydrogenase phosphorylation, promoting its enzymatic activity, or indirectly modulate PDK3 through upstream signaling pathways. These diverse inhibitors offer a comprehensive toolkit for researchers exploring metabolic reprogramming and its potential implications in various cellular contexts. Understanding the detailed biochemical and cellular pathways influenced by these inhibitors is crucial for unraveling the complexity of PDK3 regulation.